Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Zocca Mai-Britt, Chief Executive Officer. Officer active across 1 company, notably IO Biotech, Inc.. Aggregated, 3 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 9 August 2023. The latest transaction was disclosed on 23 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Mai-Britt Zocca is Chief Executive Officer of IO Biotech, Inc. She leads the company with a focus on innovation and the development of new treatments. Her leadership is essential in achieving IO Biotech's objectives.